Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2014 ◽
Vol 46
(10)
◽
pp. 936-942
◽
Keyword(s):
Keyword(s):
Keyword(s):